Seeing to Learn in Sierra Leone

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial was terminated before it completed — do you know why it ended early, and does that affect whether the findings about children's learning outcomes and emotional wellbeing from correcting refractive errors are reliable enough to guide our decisions?
2. 2Since this study was conducted in Sierra Leone and focused on foundational math, literacy, anxiety, and social-emotional outcomes in children, how relevant are those findings to our specific situation, given differences in healthcare access and school environments?
3. 3The trial looked at prosocial behavior and emotional wellbeing alongside vision correction — is there evidence from this or similar studies that getting the right glasses or treatment could meaningfully help with a child's anxiety or social difficulties, or is that still uncertain?
4. 4Because this trial has been terminated and has no listed phase, meaning it wasn't a standard drug or device safety study, what does that mean for how confident we can be that correcting refractive errors improves learning outcomes, and are there completed studies we should look at instead?
5. 5Are there currently active or completed programs — either clinical trials or established interventions — that offer vision correction for refractive errors with a proven track record, so we can compare those options to what this terminated trial was trying to do?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.